We are live on ! Find out more
TTPH

Tetraphase Pharmaceuticals, Inc.
TTPH

Delisted

TTPH was delisted on the 28th of July, 2020.

Back to rankings

41 hedge funds and large institutions have $56.8M invested in Tetraphase Pharmaceuticals, Inc. in 2013 Q2 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
+41
Holders Change %
–
% of All Funds
1.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
41
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$120K +$130K +820 New
Bank of America
27
Bank of America
North Carolina
$114K +$127K +805 New
TA
28
Teachers Advisors
New York
$105K +$118K +744 New
TRCT
29
Tower Research Capital (TRC)
New York
$96K +$107K +677 New
ARTA
30
A.R.T. Advisors
New York
$82K +$93.1K +588 New
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$76K +$85.8K +542 New
BJ
32
BlackRock Japan
Japan
$72K +$81.2K +513 New
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$70K +$79.3K +501 New
Deutsche Bank
34
Deutsche Bank
Germany
$48K +$54.5K +344 New
SO
35
STRS Ohio
Ohio
$38K +$42.8K +270 New
NFA
36
Nationwide Fund Advisors
Ohio
$25K +$28.7K +181 New
Citigroup
37
Citigroup
New York
$14K +$15.8K +100 New
Bank of Montreal
38
Bank of Montreal
Ontario, Canada
$5K +$5.23K +33 New
AllianceBernstein
39
AllianceBernstein
Tennessee
$5K +$5.7K +36 New
Ameriprise
40
Ameriprise
Minnesota
$5K +$5.7K +36 New
Barclays
41
Barclays
United Kingdom
$4K +$4.75K +30 New
1
2

TTPH Hedge Fund Activity: Q2 2013 in Review

41 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q2 2013, worth a combined $56.8M.

Buyers outnumbered sellers: 41 funds opened new TTPH positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.

  • 41 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $56.8M of Tetraphase Pharmaceuticals, Inc. stock for Q2 2013.
  • 41 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q2 2013 and 0 closed out, a net change of +41 holders.

Based on aggregated 13F filings for Q2 2013.